Projects per year
Fingerprint
Dive into the research topics where Alex Adjei is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Mayo Comprehensive Cancer Center Grant
Diasio, R. B., Fonseca, R., Salisbury, J. L., Pandey, A., Baker, D. J., Federspiel, M. J., Reid, J. M., Finnes, H., Cicek, M., Greipp, P. T., Wieben, E. D., Flotte, T. J., Kocher, J., Dueck, A., Yost, K. J., Anastasiadis, P. Z., Adjei, A., Borad, M. J., Knutson, K. L., Bekaii-Saab, T., Ansell, S. M., Sarkaria, J. N., Goetz, M. P., Loprinzi, C. L., Cerhan, J. R., Doubeni, C. A., Kumar, S. K., Dispenzieri, A., Willman, C., Prendergast, F. G., Kovach, J. S., Moertel, C., Welter, J., Jatoi, A., Mc Niven, M. A. & Galanis, E.
12/31/89 → 2/28/23
Project: Research project
-
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
Adjei, A., Diaz, R. M. & Brunton, B.
9/20/18 → 8/31/21
Project: Research project
-
Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.
Adjei, A., Lele, S., Levine, E., Singh, A. K. & Ernstoff, M.
5/6/14 → 2/28/19
Project: Research project
-
NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis
Erlichman, C., Haluska, P. R. J., Ramanathan, R. & Adjei, A.
4/7/14 → 2/28/21
Project: Research project
-
Research output
-
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA
ANSELMA collaborative group, May 2022, In: European Journal of Cancer. 166, p. 112-125 14 p.Research output: Contribution to journal › Review article › peer-review
-
Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer
Desai, A., Abdayem, P., Adjei, A. A. & Planchard, D., Jan 2022, In: Lung Cancer. 163, p. 96-106 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Investigation of sex and gender differences in oncology gains momentum: ESMO announces the launch of a Gender Medicine Task Force
Özdemir, B. C., Oertelt-Prigione, S., Adjei, A. A., Borchmann, S., Haanen, J. B., Letsch, A., Mir, O., Quaas, A., Verhoeven, R. H. A. & Wagner, A. D., Feb 2022, In: Annals of Oncology. 33, 2, p. 126-128 3 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies
Hubbard, J. M., Yin, J., Schenk, E. L., Qin, R., Reid, J. M., Strand, C., Fiskum, J., Menefee, M., Lin, G., Doyle, L. A., Ivy, P., Erlichman, C., Adjei, A., Haluska, P. & Costello, B. A., Feb 2022, In: Investigational New Drugs. 40, 1, p. 115-123 9 p.Research output: Contribution to journal › Article › peer-review
-
Trends in Prices of Drugs Used to Treat Metastatic Non-Small Cell Lung Cancer in the US from 2015 to 2020
Desai, A., Scheckel, C., Jensen, C. J., Orme, J., Williams, C., Shah, N., Leventakos, K. & Adjei, A. A., 2022, (Accepted/In press) In: JAMA Network Open. p. E2144923Research output: Contribution to journal › Article › peer-review
Open Access